down arrow

MetLife, Inc.

  • Market Cap: Large Cap
  • Industry: Insurance
  • ISIN: US59156R1086
USD
78.03
0.52 (0.67%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

77.4178.23

52 Week

65.2188.09
Valuation
Technical
Day's Volume

CASH

4.2 M

Shareholding (Mar 2025)

FII

15.81%

Held by 428 FIIs

DII

51.75%

Held by 86 DIIs

Promoter

0.01%

How big is MetLife, Inc.?

22-Jun-2025

As of Jun 18, MetLife, Inc. has a market capitalization of $78.85 billion, with total assets of $677.46 billion and a consolidated net profit of $4.52 billion for the latest four quarters.

As of Jun 18, MetLife, Inc. has a market capitalization of 78,851.05 million, categorizing it as a Large Cap company.<BR><BR>As of Jun 18, the company reported net sales of 0.00 million for the latest four quarters, while the consolidated net profit for the same period was 4,519.00 million.<BR><BR>As of Dec 24, the reporting period shows shareholder's funds of 27,445.00 million and total assets amounting to 677,457.00 million.

Read More

What does MetLife, Inc. do?

22-Jun-2025

MetLife, Inc. is a large-cap provider of life insurance, annuities, employee benefits, and asset management. As of March 2025, it reported a net profit of $950 million and has a market cap of approximately $78.85 billion.

Overview:<BR>MetLife, Inc. is a provider of life insurance, annuities, employee benefits, and asset management, operating within the insurance industry and classified as a large-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Profit: 950 Million (Quarterly Results - Mar 2025) <BR>Market Cap: USD 78,851.05 Million (Large Cap)<BR><BR>Key Metrics:<BR>P/E: 18.00 <BR>Dividend Yield: 210.06% <BR>Debt Equity: -999,999.00 <BR>Return on Equity: 16.38% <BR>Price to Book: 2.87<BR><BR>Contact Details:<BR>Address: 200 Park Ave, NEW YORK NY: 10166-0005 <BR>Tel: 1 212 5785500 <BR>Website: https://www.metlife.com/

Read More

Who are in the management team of MetLife, Inc.?

22-Jun-2025

As of March 2022, MetLife, Inc.'s management team includes Dr. Robert Hubbard (Independent Chairman), Mr. Michel Khalaf (President and CEO), and several Independent Directors: Ms. Cheryl Grise, Mr. Carlos Gutierrez, Mr. Gerald Hassell, Mr. David Herzog, and Mr. Edward Kelly. They are responsible for the company's strategic direction and governance.

As of March 2022, the management team of MetLife, Inc. includes the following individuals:<BR><BR>- Dr. Robert Hubbard, who serves as the Independent Chairman of the Board.<BR>- Mr. Michel Khalaf, who is the President, Chief Executive Officer, and Director.<BR>- Ms. Cheryl Grise, who is an Independent Director.<BR>- Mr. Carlos Gutierrez, who is also an Independent Director.<BR>- Mr. Gerald Hassell, another Independent Director.<BR>- Mr. David Herzog, serving as an Independent Director.<BR>- Mr. Edward Kelly, who is an Independent Director as well.<BR><BR>This team plays a crucial role in guiding the company's strategic direction and governance.

Read More

Is MetLife, Inc. overvalued or undervalued?

20-Sep-2025

As of August 4, 2025, MetLife, Inc. is fairly valued with a P/E ratio of 18, a Price to Book Value of 2.94, and a PEG Ratio of 0.18, indicating potential growth, although it has underperformed the S&P 500 over the past three years with a return of 21.50%.

As of 4 August 2025, the valuation grade for MetLife, Inc. moved from expensive to fair. The company appears fairly valued based on its current metrics. Key ratios include a P/E ratio of 18, a Price to Book Value of 2.94, and an impressive PEG Ratio of 0.18, indicating potential for growth relative to its price.<BR><BR>In comparison to peers, MetLife's P/E ratio of 18.69 is slightly lower than Progressive Corp.'s 18.83, while The Travelers Cos., Inc. stands out with a much higher P/E of 40.11, suggesting that MetLife may offer better value at its current price point. Notably, over the past three years, MetLife has returned 21.50%, which is significantly lower than the S&P 500's 70.41% return, indicating that while the stock is fairly valued, it has lagged behind broader market performance.

Read More

Is MetLife, Inc. technically bullish or bearish?

20-Sep-2025

As of September 9, 2025, MetLife, Inc. shows a mildly bullish technical trend, supported by a bullish weekly MACD and Bollinger Bands, despite mixed signals from other indicators and underperformance compared to the S&P 500 in the short term.

As of 9 September 2025, the technical trend for MetLife, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals across time frames. The Bollinger Bands show a mildly bullish stance on the monthly chart, which supports the overall bullish trend. However, daily moving averages are mildly bearish, suggesting short-term weakness. The KST is bullish weekly but mildly bearish monthly, and the Dow Theory indicates a mildly bearish weekly trend but a mildly bullish monthly trend. <BR><BR>In terms of performance, MetLife has underperformed the S&P 500 in the year-to-date and one-year periods, with returns of -3.43% and -0.23% compared to the S&P 500's 12.22% and 17.14%, respectively. However, over the three-year period, MetLife has returned 21.50%, outperforming the S&P 500's 70.41%. Overall, the current technical stance is mildly bullish, driven primarily by the weekly MACD and Bollinger Bands.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate of 0%

 
2

The company has declared Positive results for the last 5 consecutive quarters

3

With ROE of 16.38%, it has a expensive valuation with a 2.94 Price to Book Value

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Insurance

stock-summary
Market cap

USD 80,124 Million (Large Cap)

stock-summary
P/E

18.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

208.83%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

15.48%

stock-summary
Price to Book

2.89

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
735 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.55%
0%
-4.55%
6 Months
-0.99%
0%
-0.99%
1 Year
-8.61%
0%
-8.61%
2 Years
20.88%
0%
20.88%
3 Years
1.46%
0%
1.46%
4 Years
31.32%
0%
31.32%
5 Years
60.99%
0%
60.99%

MetLife, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
MetLife, Inc. Experiences Valuation Adjustment Amid Competitive Insurance Market Dynamics

MetLife, Inc. Experiences Valuation Adjustment Amid Competitive Insurance Market Dynamics

MetLife, Inc. has recently adjusted its valuation, with its current price at $79.82. The company has a P/E ratio of 18, a price-to-book value of 2.94, and a PEG ratio of 0.18. Despite a 1.79% return over the past year, it has shown long-term resilience with a 110.89% return over five years.

Read More
MetLife, Inc. Experiences Valuation Adjustment Amid Competitive Insurance Market Dynamics

MetLife, Inc. Experiences Valuation Adjustment Amid Competitive Insurance Market Dynamics

MetLife, Inc. has recently adjusted its valuation, with its stock price at $78.68. Over the past year, it has underperformed compared to the S&P 500. Key metrics include a P/E ratio of 18, a price-to-book value of 2.94, and a notable dividend yield of 204.59%.

Read More
MetLife, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Landscape

MetLife, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Landscape

MetLife, Inc. has recently adjusted its valuation, showcasing a competitive price-to-earnings ratio of 18 and a price-to-book value of 2.94. The company maintains a strong dividend yield and return on equity, while its long-term performance remains solid despite recent challenges compared to the broader market.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
1.36%
EBIT Growth (5y)
0
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
23.81%
Dividend Payout Ratio
36.26%
Pledged Shares
0
Institutional Holding
74.60%
ROCE (avg)
0
ROE (avg)
9.10%
Valuation key factors
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
2.94
EV to EBIT
NA
EV to EBITDA
EV to Capital Employed
7.65
EV to Sales
0.84
PEG Ratio
0.18
Dividend Yield
204.59%
ROCE (Latest)
ROE (Latest)
16.38%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 157 Schemes (32.36%)

Foreign Institutions

Held by 428 Foreign Institutions (15.81%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -22.63% vs -25.49% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "269.00",
          "val2": "258.00",
          "chgp": "4.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "735.00",
          "val2": "950.00",
          "chgp": "-22.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "72.00%",
          "val2": "86.80%",
          "chgp": "-1.48%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 177.40% vs -69.78% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "714.00",
          "val2": "718.00",
          "chgp": "-0.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1,037.00",
          "val2": "1,045.00",
          "chgp": "-0.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4,444.00",
          "val2": "1,602.00",
          "chgp": "177.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "93.80%",
          "val2": "47.90%",
          "chgp": "4.59%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
0.00
0.00
Interest
269.00
258.00
4.26%
Exceptional Items
0.00
0.00
Consolidate Net Profit
735.00
950.00
-22.63%
Operating Profit Margin (Excl OI)
72.00%
86.80%
-1.48%
USD in Million.
stock-summary Compare with Peers
Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -22.63% vs -25.49% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
714.00
718.00
-0.56%
Interest
1,037.00
1,045.00
-0.77%
Exceptional Items
0.00
0.00
Consolidate Net Profit
4,444.00
1,602.00
177.40%
Operating Profit Margin (Excl OI)
93.80%
47.90%
4.59%
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 177.40% vs -69.78% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About MetLife, Inc. stock-summary
stock-summary
MetLife, Inc.
Insurance
MetLife, Inc. is a provider of life insurance, annuities, employee benefits and asset management. The Company's segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses. Its Asia segment offers products, including life insurance; accident and health insurance, and retirement and savings products. Latin America offers products, including life insurance, and retirement and savings products. Life insurance includes universal, variable and term life products. EMEA offers products, including life insurance, accident and health insurance, retirement and savings products, and credit insurance.
Company Coordinates stock-summary
Company Details
200 Park Ave , NEW YORK NY : 10166-0005
stock-summary
Tel: 1 212 5785500
stock-summary
https://www.metlife.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."